Connection

Loreto Gesualdo to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Loreto Gesualdo has written about Dose-Response Relationship, Drug.
Loreto Gesualdo
Connection Strength
0.024
Dose-Response Relationship, Drug
  1. DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS. J Am Soc Nephrol. 2018 11; 29(11):2745-2754.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.